CDKL3 and cholangiocarcinoma: Recent studies have investigated the oncogenic role of CDKL3 in various tumors, including glioma [6], oesophageal squamous cell carcinoma [10], osteosarcoma [11], colorectal cancer [12], breast cancer [39], and cholangiocarcinoma [8].